Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients

Table 1 Clinical variables of the patients with or without congestive heart failure

Items	No CHF (n = 88)	CHF (n = 98)	P value
Age (years)	62.45 ± 7.75	66.73 ± 11.19	0.037*
Height (cm)	158.35 ± 6.98	160.06 ± 7.73	0.268
Body weight (kg)	71.62 ± 10.48	72.39 ± 13.53	0.761
Waist circumference (cm)	95.11 ± 8.74	96.99 ± 10.25	0.384
Body mass index (BMI; kg/m²)	28.57 ± 3.79	28.09 ± 3.85	0.547
Body fat mass (%)	36.19 ± 7.36	36.91 ± 6.89	0.634
White blood count (x1000/ul)	7.01 ± 1.99	6.91 ± 1.75	0.805
Haemoglobulin (g/dl)	13.64 ± 1.82	13.86 ± 1.65	0.549
Albumin (g/dl)	4.50 ± 0.27	4.43 ± 0.24	0.241
Globulin (g/dl)	2.90 ± 0.48	2.94 ± 0.41	0.608
Total cholesterol (mg/dl)	191.66 ± 43.62	192.82 ± 34.03	0.886
Triglyceride (mg/dl)	150.77 ± 84.21	161.10 ± 95.39	0.585
HDL-C (mg/dl)	48.05 ± 13.87	45.53 ± 12.74	0.365
LDL-C (mg/dl)	127.00 ± 43.38	124.94 ± 29.83	0.788
Fasting glucose (mg/dl)	117.73 ± 34.78	123.45 ± 69.92	0.590
Blood urea nitrogen (mg/dl)	16.16 ± 4.58	17.18 ± 4.96	0.310
Creatinine (mg/dL)	0.81 ± 0.20	0.85 ± 0.18	0.202
CRP (mg/dl)	0.28 ± 0.26	0.40 ± 0.59	0.972
Systolic pressure (mmHg)	130.88 ± 7.32	131.35 ± 11.26	0.819
Diastolic pressure (mmHg)	74.49 ± 8.10	75.06 ± 7.60	0.730
Insulin (μU/dl)	11.22 ± 10.85	11.11 ± 7.95	0.462
HOMA-IR	3.08 ± 2.59	3.50 ± 3.68	0.620
HOMA-β	115.55 ± 165.54	94.43 ± 65.74	0.358
LANP (ng/ml)	2.25 ± 2.01	3.77 ± 4.41	0.035*

*P < 0.05 was considered statistically significant after performing the Student t-test or Mann–Whitney U test (LANP, CRP, fasting glucose, insulin, HOMA-IR, HOMA-β).
CHF, congestive heart failure; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; CRP, C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of beta cell function; LANP, long-acting natriuretic peptide.

ISSN: 1758-5996